department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

UCB SA · catalysts · pharmadog

← back to UCB SA

Catalysts for UCB SA

63 tracked

BRIVARACETAM — FDA approval

BRIVARACETAM — FDA approval

BRIVARACETAM — FDA approval

BRIVARACETAM — FDA approval

BRIVARACETAM — FDA approval

BRIVARACETAM — FDA approval

ZILBRYSQ (ZILUCOPLAN SODIUM) — FDA approval

RYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approval

rozanolixizumab

KYGEVVI (DOXECITINE) — FDA approval

(doxecitine + doxribtimine)

FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approval

fenfluramine hydrochloride

CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval

certolizumab pegol

FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approval

fenfluramine hydrochloride

ZILBRYSQ (ZILUCOPLAN SODIUM) — FDA approval

ZILBRYSQ (ZILUCOPLAN SODIUM) — FDA approval

CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval

certolizumab pegol

RYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approval

rozanolixizumab

ZILBRYSQ (ZILUCOPLAN SODIUM) — FDA approval

FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approval

fenfluramine hydrochloride

ZILBRYSQ (ZILUCOPLAN SODIUM) — FDA approval

FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approval

fenfluramine hydrochloride

CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval

certolizumab pegol

ZILBRYSQ (ZILUCOPLAN SODIUM) — FDA approval

FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approval

fenfluramine hydrochloride

FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approval

fenfluramine hydrochloride

RYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approval

rozanolixizumab

FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approval

fenfluramine hydrochloride

FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approval

fenfluramine hydrochloride

CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval

certolizumab pegol

FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approval

fenfluramine hydrochloride

BRIVARACETAM — FDA approval

← prevpage 1 of 3next →